Citations Report

Citation Index - Clinical Investigation [920 Articles]

The articles published in Clinical Investigation have been cited 920 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Clinical Investigation.

  • Miller F, Björnsson M, Svensson O, Karlsten R (2014) Experiences with an adaptive design for a dose-finding study in patients with osteoarthritis. Contemporary clinical trials 37: 189-199.

    View at Publisher | View at Google Scholar
  • Cuffe RL, Lawrence D, Stone A, Vandemeulebroecke M (2014) When is a seamless study desirable? Case studies from different pharmaceutical sponsors. Pharmaceutical statistics 13: 229-237.

    View at Publisher | View at Google Scholar
  • Zhang L, Rosenberger WF (2014) Response-Adaptive Randomization for Clinical Trials. InPractical Considerations for Adaptive Trial Design and Implementation: 183-199.

    View at Publisher | View at Google Scholar
  • Rakemann T. A comparative study of the different approaches for approval of new HIV drugs to guidelines of the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) including possible implications on future drug development (Doctoral dissertation, Rheinische Friedrich-Wilhelms-Universität Bonn).

    View at Publisher | View at Google Scholar
  • Esparza J (2013) A brief history of the global effort to develop a preventive HIV vaccine. Vaccine 31: 3502-3518.

    View at Publisher | View at Google Scholar
  • Excler JL, Tomaras GD, Russell ND (2013) Novel directions in HIV-1 vaccines revealed from clinical trials. Current opinion in HIV and AIDS 8: 421-431.

    View at Publisher | View at Google Scholar
  • A Day T, G Kublin J (2013) Lessons learned from HIV vaccine clinical efficacy trials. Current HIV research 11: 441-449.

    View at Publisher | View at Google Scholar
  • Lithgow KV, Cameron CE (2017) Vaccine development for syphilis. Expert Review of Vaccines 16: 37-44.

    View at Publisher | View at Google Scholar
  • Engsig FN, Zangerle R, Katsarou O, Dabis F, Reiss P, et al. (2014) Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery. Clinical infectious diseases 58: 1312-1321.

    View at Publisher | View at Google Scholar
  • Olson AD, Meyer L, Prins M, Thiebaut R, Gurdasani D, et al. (2014) An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration. PloS one 9: 86719.

    View at Publisher | View at Google Scholar
  • Olson AD, Guiguet M, Zangerle R, Gill J, Perez-Hoyos S, et al. (2014) Evaluation of rapid progressors in HIV infection as an extreme phenotype. JAIDS Journal of Acquired Immune Deficiency Syndromes 67: 15-21.

    View at Publisher | View at Google Scholar
  • Giganti MJ, Luz PM, Caro-Vega Y, Cesar C, Padgett D, et al. (2015) Koenig S, Echevarria J, McGowan CC, Shepherd BE. A comparison of seven cox regression-based models to account for heterogeneity across multiple HIV treatment cohorts in Latin America and the Caribbean. AIDS research and human retroviruses 31: 496-503.

    View at Publisher | View at Google Scholar
  • Judd A, Duong T, Galli L, Goetghebuer T, Ene L, et al. (2014) Post‐licensing safety of fosamprenavir in HIV‐infected children in Europe. pharmacoepidemiology and drug safety 23: 321-325.

    View at Publisher | View at Google Scholar
  • Jarrin I, Pantazis N, Dalmau J, Phillips AN, Olson A, et al. (2015) Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?. AIDS 29: 2323-2333.

    View at Publisher | View at Google Scholar
  • Olson AD, Walker AS, Suthar AB, Sabin C, Bucher HC, et al. (1999) Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death. Journal of acquired immune deficiency syndromes 73: 100.

    View at Publisher | View at Google Scholar
  • Fidler S, Olson AD, Bucher HC, Fox J, Thornhill J, et al. (2017) Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 74: 126-133.

    View at Publisher | View at Google Scholar
  • Donaldson AE, Gordon MS, Melvin GA, Barton DA, Fitzgerald PB (2014) Addressing the needs of adolescents with treatment resistant depressive disorders: a systematic review of rTMS. Brain stimulation 7: 7-12.

    View at Publisher | View at Google Scholar
  • Gordon M, Melvin G (2014) Risk assessment and initial management of suicidal adolescents. Australian family physician 43: 367.

    View at Publisher | View at Google Scholar
  • Krige A, Pattison N, Booth M, Walsh T. Co-enrolment to intensive care studies–a UK perspective.

    View at Publisher | View at Google Scholar
  • Huang DT, Angus DC, Moss M, Thompson BT, Ferguson ND, et al. (2017) Ginde A, Gong MN, Gundel S, Hayden DL, Hite RD, Hou PC. Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome. Annals of the American Thoracic Society 14: 124-33.

    View at Publisher | View at Google Scholar
  • Mah R, Thomas JR, Shafer CM. Drug discovery considerations in the development of covalent inhibitors. Bioorganic & medicinal chemistry letters. 2014 Jan 1;24(1):33-9.

    View at Publisher | View at Google Scholar
  • Zhou W, Liu X, Tu Z, Zhang L, Ku X, et al. (2013) Discovery of Pteridin-7 (8 H)-one-based irreversible inhibitors targeting the epidermal growth factor receptor (EGFR) Kinase T790M/L858R mutant. Journal of medicinal chemistry 56: 7821-7837.

    View at Publisher | View at Google Scholar
  • Qin X, Li Z, Yang L, Liu P, Hu L, et al. (2016) Discovery of new [1, 4] dioxino [2, 3-f] quinazoline-based inhibitors of EGFR including the T790M/L858R mutant. Bioorganic & medicinal chemistry 24: 2871-2881.

    View at Publisher | View at Google Scholar
  • Hughes-Morley A, Young B, Waheed W, Small N, Bower P (2015) Factors affecting recruitment into depression trials: systematic review, meta-synthesis and conceptual framework. Journal of affective disorders 172: 274-290.

    View at Publisher | View at Google Scholar
  • Crome P, Cherubini A, Oristrell J (2014) The PREDICT (increasing the participation of the elderly in clinical trials) study: the charter and beyond. Expert review of clinical pharmacology 7: 457-468.

    View at Publisher | View at Google Scholar
  • Barton S, Karner C, Salih F, Baldwin DS, Edwards SJ (2014) Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review. Health Technology Assessment 18: 1-60.

    View at Publisher | View at Google Scholar
  • Parsons S, Starling B, Mullan-Jensen C, Tham SG, Warner K, et al. (2015) What the public knows and wants to know about medicines research and development: a survey of the general public in six European countries. BMJ open 5: e006420.

    View at Publisher | View at Google Scholar
  • De Spiegeleer B, Wynendaele E, Bracke N, Veryser L, Taevernier L, et al. (2016) Degroote A, Stalmans S. Regulatory development of geriatric medicines: To GIP or not to GIP?. Ageing research reviews 27: 23-36.

    View at Publisher | View at Google Scholar
  • Bartlam B, Waterfield J, Bishop A, Holden MA, Barlas P, et al. (2016) Ismail KM, Kettle C, Foster NE. The Role of Qualitative Research in Clinical Trial Development The EASE Back Study. Journal of Mixed Methods Research 13:1558689816656740.

    View at Publisher | View at Google Scholar
  • Cherubini A, Crome P (2016) The exclusion of older subjects from clinical trials. Clinical trials in older adults 12: 1-22.

    View at Publisher | View at Google Scholar
  • Crome AC (2015) The exclusion of older subjects from clinical trials: the PREDICT study. Clinical Trials in Older Adults 28: 1.

    View at Publisher | View at Google Scholar
  • Farrand P, Matthews J, Dickens C, Anderson M, Woodford J (2016) Psychological interventions to improve psychological well-being in people with dementia or mild cognitive impairment: systematic review and meta-analysis protocol. BMJ open 6: e009713.

    View at Publisher | View at Google Scholar
  • Lavan A, Gallagher P, O’Mahony D (2016) Future Perspectives in Drug Therapy of Older Adults. InDeveloping Drug Products in an Aging Society: 737-757.

    View at Publisher | View at Google Scholar
  • Crome P, Pleming J (2016) Healthcare Provision in an Aging Society—The European Perspective. InDeveloping Drug Products in an Aging Society: 23-44.

    View at Publisher | View at Google Scholar
  • Rouette J, Blazeby J, King M, Calvert M, Peng Y, et al. (2015)Meyer RM, Ringash J, Walker M, Brundage MD. Integrating health-related quality of life findings from randomized clinical trials into practice: an international study of oncologists’ perspectives. Quality of Life Research 24: 1317-1325.

    View at Publisher | View at Google Scholar
  • Bantug ET, Coles T, Smith KC, Snyder CF, Rouette J, Brundage (2016) Graphical displays of patient-reported outcomes (PRO) for use in clinical practice: What makes a pro picture worth a thousand words?. Patient education and counseling 99: 483-490.

    View at Publisher | View at Google Scholar
  • Bratton DJ. Design issues and extensions of multi-arm multi-stage clinical trials (Doctoral dissertation, UCL (University College London)).

    View at Publisher | View at Google Scholar
  • Dauti A, Gerstl B, Chong S, Chisholm O, Anazodo A (2017) Improvements in Clinical Trials Information Will Improve the Reproductive Health and Fertility of Cancer Patients. Journal of Adolescent and Young Adult Oncology. 2017 Feb 16.

    View at Publisher | View at Google Scholar
  • Tan CJ, Yang JL, Crowe P, Goldstein D (2013) Targeted therapy in soft tissue sarcoma—a novel direction in therapeutics. Chinese clinical oncology 2.

    View at Publisher | View at Google Scholar
  • Rothschild SI, Gautschi O, Batliner J, Gugger M, Fey MF, et al. (2016) MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors. Lung Cancer.

    View at Publisher | View at Google Scholar
  • Amarilyo G, Lourenço EV, Shi FD, La Cava A (2014) IL-17 promotes murine lupus. The Journal of Immunology 193: 540-243.

    View at Publisher | View at Google Scholar
  • Santoro N, Braunstein GD, Butts CL, Martin KA, McDermott M, et al. (2016) Pinkerton JV. Compounded bioidentical hormones in endocrinology practice: an endocrine society scientific statement. The Journal of Clinical Endocrinology & Metabolism. 2016 Apr 1;101(4):1318-43.

    View at Publisher | View at Google Scholar
  • Durham NC. Personal Information Name: Prema Menezes.

    View at Publisher | View at Google Scholar
  • Jang IS, Neto EC, Guinney J, Friend SH, Margolin AA (2014) Systematic assessment of analytical methods for drug sensitivity prediction from cancer cell line data. InPacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2014 (p. 63). NIH Public Access.

    View at Publisher | View at Google Scholar
  • Wheeler DB, Zoncu R, Root DE, Sabatini DM, Sawyers CL (2015) Identification of an oncogenic RAB protein. Science 350: 211-217.

    View at Publisher | View at Google Scholar
  • Jang IS, Dienstmann R, Margolin AA, Guinney J (2015) STEPWISE GROUP SPARSE REGRESSION (SGSR): GENE-SET-BASED PHARMACOGENOMIC PREDICTIVE MODELS WITH STEPWISE SELECTION OF FUNCTIONAL PRIORS. InPacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 20: 32.

    View at Publisher | View at Google Scholar
  • Ennis L, Wykes T (2013) Impact of patient involvement in mental health research: longitudinal study. The British Journal of Psychiatry 203: 381-386.

    View at Publisher | View at Google Scholar
  • Sin J, Henderson C, Spain D, Gamble C, Norman I (2016) What factors influence successful recruitment of siblings of individuals with first episode psychosis to e‐health interventions? A qualitative study. Health Expectations.

    View at Publisher | View at Google Scholar
  • Ziegler D, Fonseca V (2015) From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy. Journal of Diabetes and its Complications 29: 146-156.

    View at Publisher | View at Google Scholar
  • O’Ryan M, Stoddard J, Toneatto D, Wassil J, Dull PM. A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program. Drugs. 2014 Jan 1;74(1):15-30.

    View at Publisher | View at Google Scholar

Relevant Topics